Course InformationTherapautic Area: Neurology
Format(s): Meeting Reporter, Downloadable Transcript
Credit(s): 1.0 AMA PRA Category 1 Credit(s)™
Activity Dates: October 27, 2016 - October 26, 2017
This CME program will focus on the new and emerging therapeutic options for the management of patients with multiple sclerosis (MS) that were discussed at the 2016 ECTRIMS Annual Meeting in London, United Kingdom from September 14 – 17, 2016. This activity will educate healthcare providers about novel techniques and optimal management strategies for their patients with multiple sclerosis. The expert faculty will discuss the science behind new and emerging therapies, the efficacy and safety data supporting new biomarkers, and the role of biomarkers alongside traditional MS treatment options. Upon completion of this CME activity, the multidisciplinary team will be equipped with the information needed to create tailored treatment plans and improve outcomes.
Neurologists, and other healthcare professionals who care for patients with MS.
Upon completion of this activity, participants will be able to:
- Review novel science presented at ECTRIMS 2016.
- Examine clinical trial data of disease modifying therapies presented at ECTRIMS 2016.
- Develop strategies for applying up-to-date data to the management of patients with multiple sclerosis.
Fred Lublin, MD
Saunders Family Professor of Neurology
Director, Corinne Goldsmith Dickinson Center for MS
Icahn School of Medicine at Mount Sinai
New York, NY
Per Soelberg Sørensen, MD
Professor of Neurology
Director, Danish Multiple Sclerosis Center, Rigshospitalet